Skip to content

For Adult blood type incompatibility liver transplant and lymphocyte cross-match cases against humoral rejection A.surgery and anti-blood antibody lowering therapy due to previous anti-Bcell monoclonal antibodies, and plasma exchange B.post-transplantation and hepatic artery in early, portal vein infusion therapy And humoral rejection Y globulin therapy and plasma exchange combination therapy as a treatment for the reaction onset

For Adult blood type incompatibility liver transplant and lymphocyte cross-match cases against humoral rejection A.surgery and anti-blood antibody lowering therapy due to previous anti-Bcell monoclonal antibodies, and plasma exchange B.post-transplantation and hepatic artery in early, portal vein infusion therapy And humoral rejection Y globulin therapy and plasma exchange combination therapy as a treatment for the reaction onset - For Adult blood type incompatibility liver transplant and lymphocyte cross-match cases against humoral rejection

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000018224
Enrollment
20
Registered
2015-07-07
Start date
2015-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Living-donor liver transplantation

Interventions

Rituximab is used

Sponsors

Yokohama City University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Blood type incompatibility transplantation, lymphocyte cross-match cases In anesthesiology of examination, cases that have been determined to be operative

Exclusion criteria

Exclusion criteria: Patient consent was not obtained in this study

Design outcomes

Primary

MeasureTime frame
Overall survival

Secondary

MeasureTime frame
Complication rate (Clavine-Dindo classification) Graft survival rate

Countries

Japan

Contacts

Public ContactKazuhisa takeda

Yokohama City University Hospital Gastroenterological surgery

kazutake@yokohama-cu.ac.jp045-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026